The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Risk for Fracture in Women with Low Serum Levels of Thyroid-Stimulating Hormone
Abstract
BACKGROUND: Biochemical evidence of hyperthyroidism may be associated with low bone mass, particularly in older postmenopausal women, but no prospective studies of thyroid function and subsequent fracture risk have been done. OBJECTIVE: To examine the association between low levels of thyroid-stimulating hormone (TSH) and fracture in older women. DESIGN: Prospective cohort study with case-cohort sampling. SETTING: Four clinical centers in the United States. PATIENTS: 686 women older than 65 years of age from a cohort of 9704 women recruited from population-based listings between 1986 and 1988. MEASUREMENTS: Baseline assessment of calcaneal bone mass, spine radiography, and history of thyroid disease. Spine radiography was repeated after a mean follow-up of 3.7 years; nonspine fractures were centrally adjudicated. Thyroid-stimulating hormone was measured in sera obtained at baseline from 148 women with new hip fractures, 149 women with new vertebral fractures, and a subsample of 398 women randomly selected from the cohort. RESULTS: After adjustment for age, history of previous hyperthyroidism, self-rated health, and use of estrogen and thyroid hormone, women with a low TSH level (0.1 mU/L) had a threefold increased risk for hip fracture (relative hazard, 3.6 [95% CI, 1.0 to 12.9]) and a fourfold increased risk for vertebral fracture (odds ratio, 4.5 [CI, 1.3 to 15.6]) compared with women who had normal TSH levels (0.5 to 5.5 mU/L). After adjustment for TSH level, a history of hyperthyroidism was associated with a twofold increase in hip fracture (relative hazard, 2.2 [CI, 1.0 to 4.4]), but use of thyroid hormone itself was not associated with increased risk for hip fracture (relative hazard, 0.5 [CI, 0.2 to 1.3]). CONCLUSIONS: Women older than 65 years of age who have low serum TSH levels, indicating physiologic hyperthyroidism, are at increased risk for new hip and vertebral fractures. Use of thyroid hormone itself does not increase risk for fracture if TSH levels are normal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Conflicting results have also been reported regarding the risk of fractures [63,105,106] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [105]
In the citing paper
“If TH levels are elevated in the long term, patients will have a higher risk of atrial fibrillation, osteoporosis, and fracture (169, 170).”
From Levothyroxine: conventional and novel drug delivery formulations. (2023) · cites this paper as [169]
In the citing paper
“Evidence in the clinical literature suggests that there is an increased risk of bone fracture in individuals who are exposed to supratherapeutic doses of exogenous thyroid hormone for extended periods of time.”
From Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report (2017) · cites this paper as [96]
In the citing paper
“Increased bone loss and risk of fracture was also found in euthyroid postmenopausal women with fT4 and/or fT3 levels within the upper normal range and in older adults with low TSH (104–106).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [105]
In the citing paper
“A number of population-based studies have reported that certain groups of subjects with SH have increased fracture rates, including all adults (407), postmenopausal women (408), men (409), or subjects who progress to overt hyperthyroidism over time (391).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [408]
In the citing paper
“Some of these studies re-ported increased risks of overall mortality in older subjects (380,429), cardiovascular events (391), heart failure (381), and atrial fibrillation in all subjects (401) or in older subjects (384), and vertebral fractures in older women (408).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [408]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Self-citationPerspective how many women have osteoporosis?
Melton, L. J., Chrischilles, E. A., Cooper, C. C., Lane, A. W., & Riggs, B. L. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070902 · Cited by 1,400
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259 · cited 1×
“1 mIU/L or less are highly correlated with a diminished response to thyroidreleasing hormone stimulation (33) and are associated with an increased incidence of atrial fibrillation (34).”
BackgroundMarkers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
Garnero, P., Hausherr, E., Chapuy, M. C., Marcelli, C., Grandjean, H., Müller, C., Cormier, C., Bréart, G., Meunier, P. J., & Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111021 · Cited by 984
Nevitt, M. C., Ettinger, B., Black, D. M., Stone, K. L., Jamal, S. A., Ensrud, K. E., Segal, M. R., Genant, H. K., & Cummings, S. R. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-10-199805150-00001 · Cited by 841
Self-citationHow Many Women Have Osteoporosis?
Melton, L. J., Chrischilles, E. A., Cooper, C., Lane, A. W., & Riggs, B. L. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2005.20.5.886 · Cited by 708
Analysis of Case-Cohort Designs
Barlow, W. E., Ichikawa, L., Rosner, D., & Izumi, S. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00102-x · Cited by 682
Endogenous Hormones and the Risk of Hip and Vertebral Fractures among Older Women
Cummings, S. R., Browner, W. S., Bauer, D. C., Stone, K. L., Ensrud, K. E., Jamal, S. A., & Ettinger, B. B. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391104 · Cited by 660
Self-citationGenant, H. K., Jergas, M. D., Palermo, L., Nevitt, M. C., Valentin, R. S., Black, D. M., & Cummings, S. R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110716 · Cited by 637
Self-citationFactors Associated with Appendicular Bone Mass in Older Women
Bauer, D. C., Browner, W. S., Cauley, J. A., ORWOLL, E. S., Scott, J. C., Black, D. M., Tao, J. L., & Cummings, S. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-9-199305010-00001 · Cited by 563
Self-citationMARIOTTI, S., FRANCESCHI, C., COSSARIZZA, A., & PINCHERA, N. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-6-686 · Cited by 449
Screening for Thyroid Disease: An Update
Helfand, M., & Redfern, C. C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00020 · Cited by 304
Ross, D. S., Neer, R. M., Ridgway, E. C., & Daniels, G. H. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90219-1 · Cited by 279
Black, D. M., Palermo, L., Nevitt, M. C., Genant, H. K., Epstein, R. S., Valentin, R. S., & Cummings, S. R. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100610 · Cited by 250
Self-citationReport assessing vertebral fractures
Steven, R. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100403 · Cited by 241
Diamond, T. H., Nery, L., & Hales, I. B. (1991) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-72-6-1184 · Cited by 225
Long-term thyroxine treatment and bone mineral density.
Franklyn, J., Betteridge, J., Daykin, J., Oates, G., Parle, J., Heath, D., Sheppard, M., Holder, R., & Lilley, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)92423-d · Cited by 216
Axial Bone Mass in Older Women
ORWOLL, E. S., Bauer, D. C., VOGT, T. M., & Fox, K. M. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-2-199601150-00001 · Cited by 213
Self-citationAccelerated Bone Loss in Hypothyroid Patients Overtreated with L-Thyroxine
Stall, G. M., Harris, S., Sokoll, L. J., & Dawson-Hughes, B. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-4-265 · Cited by 203
Current status and performance goals for serum thyrotropin (TSH) assays.
Spencer, C., Takeuchi, M., & Kazarosyan, M. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.1.140 · Cited by 197
OSTEOPOROSIS AND FRACTURES FOLLOWING THYROTOXICOSIS
Fraser, S. A., Smith, D. A., Anderson, J., & Wilson, G. M. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91383-3 · Cited by 159
Hyperthyroidism, Thyroid Hormone Therapy, and Bone
Ross, D. S. (1994) · Thyroid · doi:10.1089/thy.1994.4.319 · Cited by 150
Prevalence of Fractures in Postmenopausal Women with Thyroid Disease
Solomon, B. L., Wartofsky, L., & Burman, K. D. (1993) · Thyroid · doi:10.1089/thy.1993.3.17 · Cited by 150
Harvey, R., McHardy, K. C., REID, I. W., Paterson, F., Bewsher, P. D., Duncan, A., & Robins, S. P. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-6-1189 · Cited by 150
Krølner, B. K., Jørgensen, J., & Nielsen, S. P. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb02873.x · Cited by 145
Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy
Greenspan, S. L., Greenspan, F. S., Resnick, N. M., Block, J. E., Friedlander, A. L., & Genant, H. K. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90066-7 · Cited by 143
Leese, G., Jung, R. T., Guthrie, C., Waugh, N. R., & Browning, M. C. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01480.x · Cited by 131
ROSS, D. S., DANIELS, G. H., & GOUVEIA, D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-764 · Cited by 126
Spencer, C. A., Schwarzbein, D., Guttler, R. B., LoPresti, J. S., & Nicoloff, J. T. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432796 · Cited by 126
Thyroxine replacement therapy and circulating lipid concentrations
Franklyn, J., Daykin, J., Betteridge, J., Hughes, E., Holder, R., Jones, S., & Sheppard, M. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00339.x · Cited by 115
Mineral and Bone Metabolism in Thyroid Disease: A Review
Auwerx, J. H., & Bouillon, R. (1986) · QJM · doi:10.1093/oxfordjournals.qjmed.a068031 · Cited by 113
Lee, M., Kim, S. Y., Lee, M. C., Cho, B. Y., Lee, H. K., Koh, C., & Min, H. K. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-3-766 · Cited by 111
Low Thyrotropin Levels Are Not Associated with Bone Loss in Older Women: A Prospective Study
Bauer, D. C., Nevitt, M. C., Ettinger, B. B., & Stone, K. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4229 · Cited by 99
Self-citationBone mineral density in postmenopausal women treated with L-thyroxine.
Adlin, E., Maurer, A. H., Marks, A. D., & Channick, B. J. (1991) · American Journal of Medicine · doi:10.1016/0002-9343(91)90577-k · Cited by 96
The Aging Thyroid: The Use of Thyroid Hormone in Older Persons
Sawin, C. T. (1989) · JAMA · doi:10.1001/jama.261.18.2653 · Cited by 94
On the Design of Synthetic Case-Control Studies
Prentice, R. L. (1986) · Biometrics · doi:10.2307/2531051 · Cited by 92
Lehmke, J., Bogner, U., Felsenberg, D., Peters, H., & Schleusener, H. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02254.x · Cited by 84
Hip fractures and the thyroid: a case‐control study
Wejda, B., Hintze, G., Katschinski, B., Olbricht, T., & Benker, G. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01172.x · Cited by 83
Effect of thyrotoxicosis and its treatment on bone mineral and muscle mass.
Bayley, T., Harrison, J., Mcneill, K., & Mernagh, J. (1980) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-50-5-916 · Cited by 78
Kiel, D. P., Cali, C., Mercier, C. A., Dawson‐Hughes, B., Hannan, M. T., & Anderson, J. J. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100719 · Cited by 61
Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism.
Ross, D. S., Ardisson, L., Nussbaum, S. R., & Meskell, M. J. (1991) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-72-2-507 · Cited by 38
Gam, A. N., JENSEN, G. F., Hasselström, K., Olsen, M., & Nielsen, K. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03346838 · Cited by 36
Effective laboratory evaluation of thyroid status.
Bayer, M. F. (1991) · The Medical clinics of North America · doi:10.1016/s0025-7125(16)30469-2 · Cited by 34
Krakauer, J. C. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.2.360 · Cited by 29
Subclinical Hypothyroidism in Older Persons
Sawin, C. T. (1995) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30293-3 · Cited by 26
Thyroid Hormone and Bone Mass: The Clinician's Dilemma
Baran, D. T. (1994) · Thyroid · doi:10.1089/thy.1994.4.143 · Cited by 24
Hyperthyroxinemia in Patients Receiving Thyroid Replacement Therapy
Grund, F. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390040119024 · Cited by 24
Thyroid hormone therapy and the skeleton
Compston, J. E. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02402.x · Cited by 22
Levothyroxine therapy and osteoporosis. An end to the controversy?
Wartofsky, L. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.11.1130 · Cited by 19
Seppel, T., Becker, A. J., Lippert, F. K., & Schlaghecke, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.4.8636386 · Cited by 13
KASHIWAI, T., Ichihara, K., Tamaki, H., Endo, Y., Kimura, M., Takeoka, K., Amino, N., & Miyai, K. (1991) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519109091635 · Cited by 11
Hallengren, B., Elmståhl, B., Berglund, J., Christensen, S. B., Elmståhl, S., Johnell, O., & Thorngren, K. ‐. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00497.x · Cited by 7
Research works printed but not linked: 7
- 10.1001/jama.1989.03420180077034 · DOI · Paper page
- Auwerx J, 1986, Q J Med, 60, 737
- 10.1001/archinte.1995.00430110024003 · DOI
- Spencer CA, 1993, J Clin Endocrinol Metab, 76, 494
- Bauer DC, 1997, J Clin Endocrinol Metab, 82, 2931
- Cummings S, 1996, J Bone Miner Res, 11, S128
- Seppel T, 1996, J Clin Endocrinol Metab, 81, 1663
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
FRAX™ and the assessment of fracture probability in men and women from the UK
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., & McCloskey, E. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0543-5 · Cited by 2,467
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
Metadata
- Authors
- Bauer, D. C., Ettinger, B., Nevitt, M. C., Stone, K. L., & for the Study of Osteoporotic Fractures Research Group
- Affiliations
- University of Minnesota (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2001-04-03
- Volume
- 134
- Issue
- 7
- Pages
- 561-568
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1992692011
- Cited by
- 467
- References
- 53
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 9 · 2023: 16 · 2022: 15 · 2021: 17 · 2020: 15 · 2019: 12 · 2018: 22 · 2017: 19 · 2016: 23 · 2015: 16 · 2014: 30 · 2013: 23 · 2012: 35
- FWCI
- 14.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08ag000629-03)
- National Institute on Aging (K08-AG-00629)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- thyroid-stimulating hormone, fracture risk, hyperthyroidism, hip fracture, vertebral fractures, postmenopausal women, older women, bone mass, thyroid hormone replacement, osteoporosis
- MeSH terms
- Aged, Follow-Up Studies, Hip Fractures, Humans, Hyperthyroidism, Male, Prospective Studies, Risk Factors, Thyroid Hormones, Thyrotropin, Bone Density, Estrogen Replacement Therapy, Case-Control Studies, Spinal Fractures, Postmenopause, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review